Use of Matrix Products for Diabetes

Diabetes incidence among population of different countries ranges from 2% to 4%. Currently, there are approximately 120 mln people, suffering from diabetes mellitus. This number grows each year.

Diabetes mellitus (DM) is an endocrine disease, characterized by chronic hyperglycemia syndrome, which is caused by insufficient level or effect of insulin, resulting in impairment of all types of metabolism, first of all, carbohydrate metabolism, vessels diseases (angiopathy), nervous system impairments (neuropathy) and impairments of other organs and systems.

According to the WHO (1985), diabetes mellitus is a state of chronic hyperglycemia, caused by impact of genetic and external factors on the organism.

There are two main types of diabetes mellitus: diabetes mellitus type 1 – insulin dependent and diabetes mellitus type 2 – non insulin dependent.

In case of insulin dependent diabetes mellitus there is a pronounced diminished insulin secretion by В(b)-cells of the Langerhans pancreatic islets (absolute deficiency of insulin secretion), such patients need continuous, life-long insulin therapy, i.e. they are insulin-dependent.

Insulin dependent diabetes mellitus is an autoimmune disease, developing in people with genetic predisposition thereto under the influence of aggravating factors of the environment. Such factors may include stress, virus infection, exposure to some toxic substances.

The following risk factors of insulin dependent diabetes mellitus increase the possibility of disease development:

  • Family history of diabetes mellitus;
  • Autoimmune diseases, in particular, endocrine diseases (autoimmune thyroiditis, chronic adrenal insufficiency);
  • Virus infections, causing inflammation of the Langerhans pancreatic islets and damage of b-cells.

Currently, the role of the genetic factor as a cause of diabetes mellitus has been proved conclusively. This is the main etiologic factor of diabetes mellitus.

Insulin dependent diabetes mellitus generally manifests itself in children and teenagers.

In case of non insulin dependent diabetes mellitus insufficient effect of insulin is the issue, resistance of peripheral tissues to insulin develops (relative insulin deficiency). Insulin replacement therapy is generally not conducted for non insulin dependent diabetes mellitus. Treatment is special diet and oral hypoglycemic medications. Lately it has been established that an early stage of insulin secretion is impaired in case of non insulin dependent diabetes mellitus.

Currently, non insulin dependent diabetes mellitus is deemed to be a heterogenic disease, characterized by impairment of insulin secretion and sensitivity of peripheral tissues to insulin (insulin resistance).

Risk factors of non insulin dependent diabetes mellitus are as follows:

  • Hereditary predisposition; genetic basis of non insulin dependent diabetes mellitus is almost 100% apparent. Risk of non insulin dependent diabetes mellitus development increases by 2 – 6 times if parents or close relatives have diabetes mellitus;
  • Obesity is the most important risk factor of non insulin dependent diabetes mellitus. Risk of non insulin dependent diabetes mellitus development is 2 times higher with first degree obesity, 5 times higher with second degree obesity and more than 10 times higher with third degree obesity. Abdominal obesity is closer related to non insulin dependent diabetes mellitus development, than peripheral distribution of fat in lower parts of the body. Non insulin dependent diabetes mellitus as a rule manifests itself after 40 years. Such patients generally have hypertension, atherosclerosis and, as it has already been mentioned above, obesity (the so called metabolic syndrome).

Diabetes mellitus may cause development of severe complications: vision impairment up to total blindness, diabetic foot up to development of lower extremities gangrene, requiring amputation, polyneuropathy. Besides, life-threatening acute complications may develop: hypoglycemic coma is most common with insulin dependent diabetes mellitus in case of insulin over-dosage or skipping meals, or hyperglycemic coma with sharp rise of glucose level in blood and development of ketoacidosis (accumulation of ketone bodies toxic to the body).

Any matrix products can be used for diabetes mellitus. You can adopt C scheme as a basis, use the applicators according to this scheme in cycles from 21 to 42 days with a one-two week break between the cycles. Be sure to use Ecostep matrix insoles and drink structurized water (the best choice is structurized Aires AquaCluster Magnet).

Given the role of stress in diabetes mellitus, it is recommended to use Aires-Relax band with Aires Black Crystal or  Aires headdress with Aires Black Crystal. You have to use glasses with optical filters. It is useful to use Aires Defender Infinity continuously (apply it on the solar plexus projection). Therapeutic effect will be more pronounced if you add volume resonators, such as Flower of Life Coherence Device, which can be used in combination with the Sphere. Volume resonators are to be applied on the solar plexus in cycles from 21 to 42 days. The session duration is 21-42 minutes.

It should be noted that the result of the matrix products application depends on the type of diabetes mellitus.

Patients with insulin dependent diabetes mellitus can get better and be able to reduce insulin dosage, however no full recovery has been observed. Nevertheless, matrix products help to avoid serious complications, e.g. loss of vision. If a patient with insulin dependent diabetes mellitus already has impaired vision, it is recommended to hold sessions with fractal glasses – the patient looks at a candle in a dark room, the candle is at 70cm distance from the eyes, the session duration is 10 minutes. It is desirable to bring the number of sessions to 6 sessions per day. The course makes 21 days.

In case of non insulin dependent diabetes mellitus matrix products have a more pronounced therapeutic effect. Correct use of the products during a long time may help to normalize glucose level in blood and to avoid dangerous complications.

S.P. Lapina, MD, PhD (Medicine)

Напишите немного о себе. Эта информация может отображаться на сайте.